Norfolk Eastern Daily Press
UK's NICE Rebuffs Glaxo's New Lupus Drug Benlysta
Wall Street Journal
NICE also said Benlysta should be compared with rituximab, sold by Roche Holding AG (ROG.VX), because some people with severe lupus currently receive rituximab, although it isn't licensed for this use. However, NICE noted there were no reliable data to ...
UK cost agency says “no” to GSK's new lupus drug
NICE says no to lupus treatment
Lupus Drug Rejected By U.K. Health Services